CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications ...
Moderna (MRNA) announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Applications for the 2025-2026 formulas for Spikevax and mNEXSPIKE, targeting the LP ...
TipRanks on MSN
Moderna provides update on pipeline progress
The company said, “Highlights from Moderna’s (MRNA) approved vaccines and prioritized portfolio include: Seasonal Vaccines: Spikevax: Approved in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback